You're leaving Lundbeck Australia

You are now leaving Please note that the information contained in the site you are linking to may not be fully compliant with the Australian regulatory environment and that product related information should be checked against the corresponding Australian consumer medicine information or by asking your doctor. Any information provided should be discussed with your health care professional and does not replace the advice and treatment of your doctor.

Click here to leave



Media Relations

Lundbeck seeks an open and active dialogue with the media. Members of the media are always welcome to direct enquiries to our media contacts who work to handle them quickly and professionally.

We are available to take media inquiries.

In Australia, please phone: Felicity Moffatt

Lundbeck Public Affairs: +61 418 677 701

About Lundbeck

H. Lundbeck A/S is a global pharmaceutical company specialisedin brain diseases. For more than 70 years, we have been at theforefront of neuroscience research. We are tirelessly dedicated torestoring brain health, so every person can be their best.

An estimated 700 million people worldwide are living with braindiseases and far too many suffer due to inadequate treatment,discrimination, a reduced number of working days, early retirementand other unnecessary consequences. Every day, we strive forimproved treatment and a better life for people living with braindiseases – we call this Progress in Mind.

Our approximately 5,800 employees in more than 50 countries areengaged in the entire value chain throughout research,development, production, marketing and sales. Our pipelineconsists of several Research and Development programs and ourproducts are available in more than 100 countries. We haveresearch centres in Denmark and the US and our productionfacilities are located in Denmark, France and Italy.